TNFRSF18 and neoplasm: The treatment ofanti-PD-1/GITR mAb increased the frequencies of interferon-γ-producingeffector T cells and decreased immunosuppressive regulatory T cells andmyeloid-derived suppressor cells, shifting an immunosuppressive tumor milieu to animmunostimulatory state in peritoneal cavity.